| 1 |
Medina Pizaño MY, Loera Arias MJ, Montes de Oca Luna R, Saucedo Cárdenas O, Ventura Juárez J, Muñoz Ortega MH. Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity. Ann Med 2023;55:543-57. [PMID: 36826975 DOI: 10.1080/07853890.2022.2164047] [Reference Citation Analysis]
|
| 2 |
Vyas K, Patel MM. Insights on drug and gene delivery systems in liver fibrosis. Asian J Pharm Sci 2023;18:100779. [PMID: 36845840 DOI: 10.1016/j.ajps.2023.100779] [Reference Citation Analysis]
|
| 3 |
Wu B, Liu DA, Guan L, Myint PK, Chin L, Dang H, Xu Y, Ren J, Li T, Yu Z, Jabban S, Mills GB, Nukpezah J, Chen YH, Furth EE, Gimotty PA, Wells RG, Weaver VM, Radhakrishnan R, Wang XW, Guo W. Stiff matrix induces exosome secretion to promote tumour growth. Nat Cell Biol 2023;25:415-24. [PMID: 36797475 DOI: 10.1038/s41556-023-01092-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Jocius D, Vajauskas D, Samuilis A, Mikelis K, Jokubauskiene S, Strupas K, Tamosiunas AE. Assessing Liver Fibrosis Using 2D-SWE Liver Ultrasound Elastography and Dynamic Liver Scintigraphy with 99mTc-mebrofenin: A Comparative Prospective Single-Center Study. Medicina 2023;59:479. [DOI: 10.3390/medicina59030479] [Reference Citation Analysis]
|
| 5 |
Sun L, Wu A, Wang X, Yang B. The regularity of nourishing-yin prescription for treating ascites due to hepatitis B cirrhosis based on data mining technology. Ann Transl Med 2023;11:183. [PMID: 36923089 DOI: 10.21037/atm-23-883] [Reference Citation Analysis]
|
| 6 |
Wang R, Liu F, Chen P, Li S, Gu Y, Wang L, Chen C, Yuan Y. Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells. Int J Biol Macromol 2023;235:123639. [PMID: 36822287 DOI: 10.1016/j.ijbiomac.2023.123639] [Reference Citation Analysis]
|
| 7 |
Bai XP, Du WJ, Xing HB, Yang GH, Bai R. Influence of ursodeoxycholic acid on blood glucose, insulin and GLP-1 in rats with liver fibrosis induced by bile duct ligation. Diabetol Metab Syndr 2023;15:18. [PMID: 36788623 DOI: 10.1186/s13098-023-00989-z] [Reference Citation Analysis]
|
| 8 |
Effat Saied N, Elmazny GM, El-Helaly RM, Farag RE, Abd El-Wahab K, Abo Hashim E, El-Zehery RR. Utility of comet assay of DNA damage in the detection of malignant transformation of chronic liver cirrhosis. Scand J Clin Lab Invest 2023;:1-7. [PMID: 36779865 DOI: 10.1080/00365513.2023.2175327] [Reference Citation Analysis]
|
| 9 |
Pozza G, Samardzic N, Giudici F, Casagranda B, DE Manzini N, Palmisano S. Inflammatory-nutritional scores in the diagnosis of NASH and liver fibrosis. Minerva Med 2023;114:29-34. [PMID: 34761883 DOI: 10.23736/S0026-4806.21.07665-5] [Reference Citation Analysis]
|
| 10 |
Xu R, He L, Vatsalya V, Ma X, Kim S, Mueller EG, Feng W, McClain CJ, Zhang X. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism. Am J Physiol Gastrointest Liver Physiol 2023;324:G142-54. [PMID: 36513601 DOI: 10.1152/ajpgi.00228.2022] [Reference Citation Analysis]
|
| 11 |
Sahu R, Goswami S, Narahari Sastry G, Rawal RK. The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives. Chem Biodivers 2023;20:e202201029. [PMID: 36703592 DOI: 10.1002/cbdv.202201029] [Reference Citation Analysis]
|
| 12 |
Junaid Dar A, John A, Ali A, Ansar A, Azam S. Chronic Liver Disease: Liver Cirrhosis and Diagnostic Features. PJHS 2023. [DOI: 10.54393/pjhs.v4i01.511] [Reference Citation Analysis]
|
| 13 |
Łotowska JM, Sobaniec-Łotowska ME, Bobrus-Chociej A, Sobaniec P. The Ultrastructure of Hepatic Stellate Cell-Macrophage Intercellular Crosstalk as a New Morphological Insight into Phenomenon of Fibrogenesis in Pediatric Autoimmune Hepatitis. J Clin Med 2023;12. [PMID: 36769672 DOI: 10.3390/jcm12031024] [Reference Citation Analysis]
|
| 14 |
Ali FE, Abd El-Aziz MK, Sharab EI, Bakr AG. Therapeutic interventions of acute and chronic liver disorders: A comprehensive review. World J Hepatol 2023;15:19-40. [PMID: 36744165 DOI: 10.4254/wjh.v15.i1.19] [Reference Citation Analysis]
|
| 15 |
Camerlo S, Ligato J, Rosati G, Carrà G, Russo I, De Gobbi M, Morotti A. Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis. Int J Mol Sci 2023;24. [PMID: 36768584 DOI: 10.3390/ijms24032262] [Reference Citation Analysis]
|
| 16 |
Zhang K, Nulali J, Zhang C, Chen Y, Cheng J, Shi X, Zhu C, Lu Y, Wang N, Han B. The association between serum vitamin A and NAFLD among US adults varied in different BMI groups: a cross-sectional study. Food Funct 2023;14:836-44. [PMID: 36321945 DOI: 10.1039/d2fo02204d] [Reference Citation Analysis]
|
| 17 |
L'Écuyer S, Charbonney E, Carrier FM, Rose CF. Implication of Hypotension in the Pathogenesis of Cognitive Impairment and Brain Injury in Chronic Liver Disease. Neurochem Res 2023. [PMID: 36635437 DOI: 10.1007/s11064-022-03854-z] [Reference Citation Analysis]
|
| 18 |
Krispin I, Mahamid M, Goldin E, Fteiha B. Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics. Ann Hepatol 2023;28:100897. [PMID: 36632976 DOI: 10.1016/j.aohep.2023.100897] [Reference Citation Analysis]
|
| 19 |
Di-Iacovo N, Pieroni S, Piobbico D, Castelli M, Scopetti D, Ferracchiato S, Della-Fazia MA, Servillo G. Liver Regeneration and Immunity: A Tale to Tell. Int J Mol Sci 2023;24. [PMID: 36674692 DOI: 10.3390/ijms24021176] [Reference Citation Analysis]
|
| 20 |
White SB, Maddirela DR. Fibrosis and Immunotherapy in Hepatocellular Carcinoma. Interdisciplinary Cancer Research 2023. [DOI: 10.1007/16833_2022_122] [Reference Citation Analysis]
|
| 21 |
Zhang M, Liu K, Zhang Q, Xu J, Liu J, Lin H, Lin B, Zhu M, Li M. Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells. Front Immunol 2023;14:1081572. [PMID: 36911723 DOI: 10.3389/fimmu.2023.1081572] [Reference Citation Analysis]
|
| 22 |
Zeliger HI. Liver cirrhosis. Oxidative Stress 2023. [DOI: 10.1016/b978-0-323-91890-9.00003-9] [Reference Citation Analysis]
|
| 23 |
Grisetti L, Võ NVT, Nguyễn NNQ, Crocè LS, Visintin A, Tiribelli C, Pascut D. MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma. Technol Cancer Res Treat 2022;21:15330338221132924. [PMID: 36537076 DOI: 10.1177/15330338221132924] [Reference Citation Analysis]
|
| 24 |
Radmanić L, Zidovec-Lepej S. The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD. Life (Basel) 2022;12. [PMID: 36556437 DOI: 10.3390/life12122072] [Reference Citation Analysis]
|
| 25 |
Chen S, Zhu J, Xue J, Wang X, Jing P, Zhou L, Cui Y, Wang T, Gong X, Lü S, Long M. Numerical simulation of flow characteristics in a permeable liver sinusoid with leukocytes. Biophys J 2022;121:4666-78. [PMID: 36271623 DOI: 10.1016/j.bpj.2022.10.022] [Reference Citation Analysis]
|
| 26 |
Hu W, Lazar MA. Modelling metabolic diseases and drug response using stem cells and organoids. Nat Rev Endocrinol 2022;18:744-59. [PMID: 36071283 DOI: 10.1038/s41574-022-00733-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
Ibrahim IM, Althagafy HS, Abd-alhameed EK, Al-thubiani W, Hassanein EH. Promising hepatoprotective effects of lycopene in different liver diseases. Life Sciences 2022;310:121131. [DOI: 10.1016/j.lfs.2022.121131] [Reference Citation Analysis]
|
| 28 |
Meng Y, Zhao T, Zhang Z, Zhang D. The role of hepatic microenvironment in hepatic fibrosis development. Ann Med 2022;54:2830-44. [PMID: 36399108 DOI: 10.1080/07853890.2022.2132418] [Reference Citation Analysis]
|
| 29 |
Liu X, Ma H, Wu R, Wang H, Xu H, Li S, Wang G, Lv G, Niu J. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing. Genes (Basel) 2022;13. [PMID: 36553468 DOI: 10.3390/genes13122201] [Reference Citation Analysis]
|
| 30 |
Peng X, Yang H, Tao L, Xiao J, Zeng Y, Shen Y, Yu X, Qin J. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway.. [DOI: 10.21203/rs.3.rs-2251158/v1] [Reference Citation Analysis]
|
| 31 |
Lu H, Zheng C, Xiong B, Xia X. Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly. BMC Gastroenterol 2022;22:470. [PMID: 36402985 DOI: 10.1186/s12876-022-02580-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Ramos-Tovar E, Muriel P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. Vitam Horm 2023;121:271-92. [PMID: 36707137 DOI: 10.1016/bs.vh.2022.09.006] [Reference Citation Analysis]
|
| 33 |
Al-Hetty HRAK, Ismaeel GL, Mohammad WT, Toama MA, Kandeel M, Saleh MM, Turki Jalil A. SRF/MRTF-A and liver cirrhosis: Pathologic associations. J Dig Dis 2022;23:614-9. [PMID: 36601855 DOI: 10.1111/1751-2980.13150] [Reference Citation Analysis]
|
| 34 |
He X, Liu T, Zhang R, Li X, Sheikh N. Associations between Extracellular Matrix Protein 1 Gene Polymorphism and Progression of Liver Disease. Genetics Research 2022;2022:1-9. [DOI: 10.1155/2022/9304264] [Reference Citation Analysis]
|
| 35 |
Ye Z, Huang Q, She Y, Hu Y, Wu M, Qin K, Li L, Zhang C, Zuo X, Wei A, Mao D, Ye Q. A meritorious integrated medical regimen for hepatic fibrosis and its complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy. Front Med (Lausanne) 2022;9:920062. [PMID: 36314011 DOI: 10.3389/fmed.2022.920062] [Reference Citation Analysis]
|
| 36 |
Chen H. Iron metabolism in nonalcoholic fatty liver disease: a promising therapeutic target. Liver Research 2022. [DOI: 10.1016/j.livres.2022.09.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Bhateja Y, Ghosh R, Sponer J, Majumdar S, Cassone G. A Cr2O3-doped graphene sensor for early diagnosis of liver cirrhosis: a first-principles study. Phys Chem Chem Phys 2022. [PMID: 36043859 DOI: 10.1039/d2cp01793h] [Reference Citation Analysis]
|
| 38 |
Kalluru R, Gadde S, Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri SP. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart. Cureus 2022. [DOI: 10.7759/cureus.27969] [Reference Citation Analysis]
|
| 39 |
Kitsugi K, Noritake H, Matsumoto M, Hanaoka T, Umemura M, Yamashita M, Takatori S, Ito J, Ohta K, Chida T, Ulmasov B, Neuschwander-Tetri BA, Suda T, Kawata K. Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway. Cell Signal 2022;99:110437. [PMID: 35970425 DOI: 10.1016/j.cellsig.2022.110437] [Reference Citation Analysis]
|
| 40 |
Van Campenhout R, Leroy K, Cooreman A, Tabernilla A, Cogliati B, Kadam P, Vinken M. Connexin-Based Channels in the Liver. Compr Physiol 2022;12:1-17. [PMID: 35950654 DOI: 10.1002/cphy.c220007] [Reference Citation Analysis]
|
| 41 |
G V, James R. PREVALENCE OF HYPOMAGNESEMIA IN CIRRHOSIS OF LIVER AND ITS ASSOCIATION WITH SEVERITYOF THE DISEASE. Asian J Pharm Clin Res 2022. [DOI: 10.22159/ajpcr.2022.v15i8.45029] [Reference Citation Analysis]
|
| 42 |
Hyun JY, Kim SK, Yoon SJ, Lee SB, Jeong JJ, Gupta H, Sharma SP, Oh KK, Won SM, Kwon GH, Cha MG, Kim DJ, Ganesan R, Suk KT. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease. Int J Mol Sci 2022;23:8749. [PMID: 35955885 DOI: 10.3390/ijms23158749] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Radmanić L, Bodulić K, Šimičić P, Vince A, Lepej SŽ. The Effect of Treatment-Induced Viral Eradication on Cytokine and Growth Factor Expression in Chronic Hepatitis C. Viruses 2022;14:1613. [PMID: 35893679 DOI: 10.3390/v14081613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Teng T, Qiu S, Zhao Y, Zhao S, Sun D, Hou L, Li Y, Zhou K, Yu X, Yang C, Li Y. Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2022;23:7841. [PMID: 35887189 DOI: 10.3390/ijms23147841] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Li Y, Yuan SL, Yin JY, Yang K, Zhou XG, Xie W, Wang Q. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis. World J Gastrointest Oncol 2022; 14(7): 1265-1280 [DOI: 10.4251/wjgo.v14.i7.1265] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 46 |
Yang L, Zhang B. Protective Mechanism of Nostoc sphaeroides Kütz. Polysaccharide on Liver Fibrosis by HFD-Induced Liver Fat Synthesis and Oxidative Stress. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/1745244] [Reference Citation Analysis]
|
| 47 |
Duan H, Zhang R, Chen X, Yu G, Song C, Jiang Y, He Y, Wan H, Shen J. Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study. Front Endocrinol 2022;13:930224. [DOI: 10.3389/fendo.2022.930224] [Reference Citation Analysis]
|
| 48 |
Auth PA, da Silva GR, Amaral EC, Bortoli VF, Manzano MI, de Souza LM, Lovato ECW, Ribeiro-Paes JT, Gasparotto Junior A, Lívero FADR. Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats. Front Pharmacol 2022;13:886122. [PMID: 35668935 DOI: 10.3389/fphar.2022.886122] [Reference Citation Analysis]
|
| 49 |
Chen Q, Peng K, Mo P, Yu C. Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers. Cancers (Basel) 2022;14:2841. [PMID: 35740507 DOI: 10.3390/cancers14122841] [Reference Citation Analysis]
|
| 50 |
Nie L, Zhang J. Clinical study of warm needling moxibustion combined with entecavir in the treatment of compensated cirrhosis due to chronic hepatitis B. J Acupunct Tuina Sci 2022;20:199-205. [DOI: 10.1007/s11726-022-1313-9] [Reference Citation Analysis]
|
| 51 |
Safarikish B, Rafiei F, Ebrahimi A, Azizi-soleiman F, Rafiei R. The Relationship Between Plasma Magnesium Concentration and Hepatic Encephalopathy in Liver Cirrhosis Patients: A Preliminary Result of a Referral Center in Iran. Middle East J Rehabil Health Stud 2022;9. [DOI: 10.5812/mejrh-122978] [Reference Citation Analysis]
|
| 52 |
Wang C, Liu J, Yan Y, Tan Y, Jinhui L. Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/1695802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Ru L, Wang XM, Niu JQ. The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis. Acta Pharmacol Sin 2022;43:1167-79. [PMID: 34893685 DOI: 10.1038/s41401-021-00819-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 54 |
Su S, Wang Q, Wei F, Zheng G. Effect of Modified Xianglian Pingwei Powder plus Glutathione and Levofloxacin Hydrochloride on Patients with Liver Cirrhosis and Positive Small Intestinal Bacterial Overgrowth. Evid Based Complement Alternat Med 2022;2022:5063088. [PMID: 35449813 DOI: 10.1155/2022/5063088] [Reference Citation Analysis]
|
| 55 |
Toc DA, Pandrea SL, Botan A, Mihaila RM, Costache CA, Colosi IA, Junie LM. Enterococcus raffinosus, Enterococcus durans and Enterococcus avium Isolated from a Tertiary Care Hospital in Romania-Retrospective Study and Brief Review. Biology (Basel) 2022;11. [PMID: 35453797 DOI: 10.3390/biology11040598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 56 |
Salatini R, Amaral J, Raimundo RD, Rocha F, de Abreu LC, Morais M, Tannuri U, Tannuri AC. Cardiac autonomic modulation in children with severe liver disease, before and after liver transplantation. Transl Pediatr 2022;11:438-47. [PMID: 35558982 DOI: 10.21037/tp-21-273] [Reference Citation Analysis]
|
| 57 |
Sarabia Aldana CA, Medina-torres L, Calderas F, Ramírez-torres LA, Núñez-ramírez D, Herrera-valencia EE, Bernad-bernad MJ, Manero O. Hemorheological and biochemical study in patients with liver cirrhosis. Physics of Fluids 2022;34:041907. [DOI: 10.1063/5.0086561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 58 |
Su Y, Lu S, Hou C, Ren K, Wang M, Liu X, Zhao S, Liu X. Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin. Int Immunopharmacol 2022;108:108683. [PMID: 35344814 DOI: 10.1016/j.intimp.2022.108683] [Reference Citation Analysis]
|
| 59 |
Sun J, Sun X, Hu S, Wang M, Ma N, Chen J, Duan F. Long noncoding RNA SNHG1 silencing accelerates hepatocyte-like cell differentiation of bone marrow-derived mesenchymal stem cells to alleviate cirrhosis via the microRNA-15a/SMURF1/UVRAG axis. Cell Death Discov 2022;8:77. [PMID: 35194023 DOI: 10.1038/s41420-022-00850-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 60 |
Zaghloul RA, Zaghloul AM, El-Kashef DH. Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways. Life Sci 2022;:120410. [PMID: 35182557 DOI: 10.1016/j.lfs.2022.120410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 61 |
Chulenbayeva L, Ilderbayev O, Suleymeneva D, Kaliyeva A, Kabdykanov S, Nurgaziyev M, Nurgozhina A, Sergazy S, Kozhakhmetov S, Kushugulova A. Prolonged Inhalation Exposure to Coal Dust on Irradiated Rats and Consequences. The Scientific World Journal 2022;2022:1-9. [DOI: 10.1155/2022/8824275] [Reference Citation Analysis]
|
| 62 |
Petrushenko VV, Grebeniuk DІ. Efficacy of partial embolization of splenic artery in patients after hemorrhage of portal genesis. KH 2022;88:47-52. [DOI: 10.26779/2522-1396.2021.11-12.47] [Reference Citation Analysis]
|
| 63 |
Hammad S, Ogris C, Othman A, Erdoesi P, Schmidt-heck W, Biermayer I, Helm B, Gao Y, Piorońska W, D’alessandro LA, Theis FJ, Ebert MP, Klingmüller U, Hengstler JG, Dooley S, Mueller NS. Repeated toxic injuries of murine liver are tolerated through microsteatosis and mild inflammation.. [DOI: 10.1101/2022.01.12.476054] [Reference Citation Analysis]
|
| 64 |
Suk KT, Koh H. New perspective on fecal microbiota transplantation in liver diseases. J Gastroenterol Hepatol 2022;37:24-33. [PMID: 34734433 DOI: 10.1111/jgh.15729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 65 |
Paulino do Nascimento LC, Cruz Neto JPR, Callou KRDA, Dejani NN, de Brito Alves JL. Probiotics for liver disease prevention and treatment. Probiotics for Human Nutrition in Health and Disease 2022. [DOI: 10.1016/b978-0-323-89908-6.00009-1] [Reference Citation Analysis]
|
| 66 |
Veraldi S, Pietrobattista A, Soglia G, Monti L, Alterio T, Mosca A, Liccardo D, Basso MS, Della Corte C, Russo L, Candusso M, Chiusolo F, Tortora F, Spada M, Maggiore G. Sarcopenia in children with chronic liver disease: Prevalence and impact on liver transplant outcomes. Front Pediatr 2022;10:1033570. [PMID: 36741094 DOI: 10.3389/fped.2022.1033570] [Reference Citation Analysis]
|
| 67 |
Lu X, Wang F. MicroRNA targeted therapy in hepatitis. MicroRNA 2022. [DOI: 10.1016/b978-0-323-89774-7.00009-1] [Reference Citation Analysis]
|
| 68 |
Wu Z, Wang J, Feng J, Ying L. MicroRNA-122-5p prevents proliferation and promotes apoptosis of hepatic stellate cells by suppressing the cellular-Abelsongene/histone deacetylases 2 pathway. Hum Exp Toxicol 2022;41:9603271221084672. [PMID: 35303413 DOI: 10.1177/09603271221084672] [Reference Citation Analysis]
|
| 69 |
Sahu N, Rakshit S, Bhaskar L. Risk factors and pathogenic mechanism–associated hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma 2022. [DOI: 10.1016/b978-0-323-98806-3.00023-4] [Reference Citation Analysis]
|
| 70 |
Maharjan S, Bonilla D, Zhang YS. 3D Bioprinting for Liver Regeneration. 3D Bioprinting and Nanotechnology in Tissue Engineering and Regenerative Medicine 2022. [DOI: 10.1016/b978-0-12-824552-1.00010-4] [Reference Citation Analysis]
|
| 71 |
Bergman ZR, Beilman GJ. Surgical Approach to Cirrhotic Patients. The Acute Management of Surgical Disease 2022. [DOI: 10.1007/978-3-031-07881-1_35] [Reference Citation Analysis]
|
| 72 |
Reed TJ, D'ambrosio D, Knollmann-ritschel BE. Educational Case: Evaluating a patient with cirrhosis. Academic Pathology 2022;9:100031. [DOI: 10.1016/j.acpath.2022.100031] [Reference Citation Analysis]
|
| 73 |
Zoratti C, Moretti R, Rebuzzi L, Albergati IV, Di Somma A, Decorti G, Di Bella S, Crocè LS, Giuffrè M. Antibiotics and Liver Cirrhosis: What the Physicians Need to Know. Antibiotics (Basel) 2021;11:31. [PMID: 35052907 DOI: 10.3390/antibiotics11010031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 74 |
Wang Y, Li N, Zheng Y, Wang A, Yu C, Song Z, Wang S, Sun Y, Zheng L, Wang G, Liu L, Yi J, Huang Y, Zhang M, Bao Y, Sun L. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3. IJMS 2021;23:104. [DOI: 10.3390/ijms23010104] [Reference Citation Analysis]
|
| 75 |
Wang N, Li X, Zhong Z, Qiu Y, Liu S, Wu H, Tang X, Chen C, Fu Y, Chen Q, Guo T, Li J, Zhang S, Zern MA, Ma K, Wang B, Ou Y, Gu W, Cao J, Chen H, Duan Y. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. J Nanobiotechnology 2021;19:437. [PMID: 34930304 DOI: 10.1186/s12951-021-01138-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 76 |
Randhawa NK, Shastri T, Hassanin EH, Randhawa S. Initial Presentation of Cirrhosis Mimicking an Ischemic Stroke. Cureus 2021;13:e19474. [PMID: 34912615 DOI: 10.7759/cureus.19474] [Reference Citation Analysis]
|
| 77 |
Zarghamravanbakhsh P, Frenkel M, Poretsky L. Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). Metabol Open 2021;12:100149. [PMID: 34870138 DOI: 10.1016/j.metop.2021.100149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 78 |
Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
van den Heuvel R. Levercirrose. nurs 2021;27:49-55. [DOI: 10.1007/s41193-021-0182-9] [Reference Citation Analysis]
|
| 80 |
Zidan MHS, Zaghloul SG, Seleem WM, Ahmed HS, Gad AI. Bacteremia as a risk factor for variceal upper gastrointestinal tract bleeding in cirrhotic patients: a hospital-based study. Egypt Liver Journal 2021;11:8. [DOI: 10.1186/s43066-021-00078-8] [Reference Citation Analysis]
|
| 81 |
Yilmaz B, Kayadibi H, Yeniova AO, Koseoglu H, Simsek Z. The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infection. Eur J Gastroenterol Hepatol 2021;33:e290-6. [PMID: 33405426 DOI: 10.1097/MEG.0000000000002038] [Reference Citation Analysis]
|
| 82 |
Xiao X, Hu Q, Deng X, Shi K, Zhang W, Jiang Y, Ma X, Zeng J, Wang X. Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. Pharmacol Res 2021;175:106005. [PMID: 34843960 DOI: 10.1016/j.phrs.2021.106005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 83 |
Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
|
| 84 |
Gamboa CM, Wang Y, Xu H, Kalemba K, Wondisford FE, Sabaawy HE. Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays. Cells 2021;10:3280. [DOI: 10.3390/cells10123280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 85 |
Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 86 |
Lee SL, Hsu WH, Tu CM, Wang WH, Yang CY, Lee HK, Chin TY. The Effects of Freshwater Clam (Corbicula fluminea) Extract on Activated Hepatic Stellate Cells. Evid Based Complement Alternat Med 2021;2021:6065168. [PMID: 34804181 DOI: 10.1155/2021/6065168] [Reference Citation Analysis]
|
| 87 |
Choi Y, Kim MS, Rhoades JH, Johnson NM, Berry CT, Root S, Chen Q, Tian Y, Fernandez RJ, Cramer Z, Adams-tzivelekidis S, Li N, Johnson FB, Lengner CJ. Patient induced pluripotent stem cell-derived hepatostellate organoids establish a basis for liver pathologies in telomeropathies.. [DOI: 10.1101/2021.11.19.469258] [Reference Citation Analysis]
|
| 88 |
Goto RL, Tablas MB, Prata GB, Espírito Santo SG, Fernandes AAH, Cogliati B, Barbisan LF, Romualdo GR. Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis. J Steroid Biochem Mol Biol 2022;215:106022. [PMID: 34774723 DOI: 10.1016/j.jsbmb.2021.106022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 89 |
Le J, Ji H, Zhou X, Wei X, Chen Y, Fu Y, Ma Y, Han Q, Sun Y, Gao Y, Wu H. Pharmacology, Toxicology, and Metabolism of Sennoside A, A Medicinal Plant-Derived Natural Compound. Front Pharmacol 2021;12:714586. [PMID: 34764866 DOI: 10.3389/fphar.2021.714586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 90 |
García-Peñarrubia P, Ruiz-Alcaraz AJ, Ruiz-Ballester M, Ramírez-Pávez TN, Martínez-Esparza M. Recent insights into the characteristics and role of peritoneal macrophages from ascites of cirrhotic patients. World J Gastroenterol 2021; 27(41): 7014-7024 [PMID: 34887625 DOI: 10.3748/wjg.v27.i41.7014] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 91 |
Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res 2021;70. [PMID: 34717063 DOI: 10.33549/physiolres.934755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 92 |
Sánchez PS, Rigual MDM, Djouder N. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development. Cancers (Basel) 2021;13:5045. [PMID: 34680192 DOI: 10.3390/cancers13205045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 93 |
Reza HA, Okabe R, Takebe T. Organoid transplant approaches for the liver. Transpl Int 2021;34:2031-45. [PMID: 34614263 DOI: 10.1111/tri.14128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 94 |
Istanbuly S, Matetic A, Mohamed MO, Panaich S, Velagapudi P, Elgendy IY, Paul TK, Alkhouli M, Mamas MA. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary Intervention. Am J Cardiol 2021;156:32-8. [PMID: 34348842 DOI: 10.1016/j.amjcard.2021.06.044] [Reference Citation Analysis]
|
| 95 |
Mir ZM, Djerboua M, Nanji S, Flemming JA, Groome PA. Predictors of Postoperative Liver Decompensation Events After Resection in Patients with Cirrhosis and Hepatocellular Carcinoma: A Population-Based Study. Ann Surg Oncol 2021. [PMID: 34549362 DOI: 10.1245/s10434-021-10801-9] [Reference Citation Analysis]
|
| 96 |
Thang Hoang D, Hien Truong TT, Viet Duc N, Anh Hoang LT, Do TT, Vinh LB, Young Yang S, Dan G, Tuan Anh L. Hepatoprotective Effects of Extract of Helicteres hirsuta Lour. on Liver Fibrosis Induced by Carbon Tetrachloride in Rats. Applied Sciences 2021;11:8758. [DOI: 10.3390/app11188758] [Reference Citation Analysis]
|
| 97 |
Luo Y, Wu B, Wu Y, Peng L, Li Z, Zhu J, Su Z, Liu J, Li S, Chong Y. Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis. Ann Transl Med 2021;9:1239. [PMID: 34532376 DOI: 10.21037/atm-21-3111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 98 |
Omeish H, Hajjaj N, Abdulelah M, Bader H. You Only Find What You Are Looking for: Concurrent Alcoholic Liver Cirrhosis and Undiagnosed Wilson's Disease. Cureus 2021;13:e17117. [PMID: 34527496 DOI: 10.7759/cureus.17117] [Reference Citation Analysis]
|
| 99 |
Park JS, Ma H, Roh YS. Ubiquitin pathways regulate the pathogenesis of chronic liver disease. Biochem Pharmacol 2021;193:114764. [PMID: 34529948 DOI: 10.1016/j.bcp.2021.114764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 100 |
Sawalha K, Gupta K, Kadado AJ, Abozenah M, Battisha A, Salerno C, Khan A, Islam AM. In-hospital outcomes of transcatheter versus surgical mitral valve repair in patients with chronic liver disease. Int J Clin Pract 2021;:e14660. [PMID: 34322958 DOI: 10.1111/ijcp.14660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 101 |
Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 102 |
Shoraka S, Mohebbi SR, Hosseini SM, Asadzadeh Aghdaei H, Zali MR. Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients. Virus Res 2021;303:198503. [PMID: 34331990 DOI: 10.1016/j.virusres.2021.198503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 103 |
Wang Z, Chen N, Li Z, Xu G, Zhan X, Tang J, Xiao X, Bai Z. The Cytosolic DNA-Sensing cGAS-STING Pathway in Liver Diseases. Front Cell Dev Biol 2021;9:717610. [PMID: 34386500 DOI: 10.3389/fcell.2021.717610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 104 |
Zhang Y, Huang C, Nie Y, Liu Q, Xiao N, Liu L, Zhu X. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:698502. [PMID: 34336902 DOI: 10.3389/fmed.2021.698502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Yang C, Chen M, Wang S, Qian R, Huang X, Wang J, Liu Z, Qin W, Wang C, Hang H, Wang H. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer.. [DOI: 10.1101/2021.06.29.450305] [Reference Citation Analysis]
|
| 106 |
Zhang X, Yuan S, Zhang X, Zhang T, Meng C, Zhuang K, Dang S. ANGPTL4 regulates CD163 expression and Kuppfer cell polarization induced cirrhosis via TLR4/NF-κB pathway. Exp Cell Res 2021;405:112706. [PMID: 34146541 DOI: 10.1016/j.yexcr.2021.112706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 107 |
Mu LY, Li SQ, Tang LX, Li R. Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis. Clinics (Sao Paulo) 2021;76:e2409. [PMID: 34133478 DOI: 10.6061/clinics/2021/e2409] [Reference Citation Analysis]
|
| 108 |
Llop E, Iruzubieta P, Perelló C, Fernández Carrillo C, Cabezas J, Escudero MD, González M, Hernández Conde M, Puchades L, Arias-Loste MT, Serra MÁ, Crespo J, Calleja JL. High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort. United European Gastroenterol J 2021. [PMID: 34077628 DOI: 10.1002/ueg2.12109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 109 |
Fan Y, Yin X. Potential therapeutic targets and biological mechanisms of Centella asiatica on hepatic fibrosis: a study of network pharmacology. Ann Transl Med 2021;9:932. [PMID: 34350247 DOI: 10.21037/atm-21-2253] [Reference Citation Analysis]
|
| 110 |
Lu MS, Lu HI, Chen TP, Chang CC, Yang TM, Chen MF. Survival of Patients with Lung Cancer in the Setting of Liver Cirrhosis: A Multicenter Propensity Score Matching Study. Cancer Manag Res 2021;13:4373-81. [PMID: 34103992 DOI: 10.2147/CMAR.S304980] [Reference Citation Analysis]
|
| 111 |
Skurikhin EG, Zhukova MA, Pan ES, Ermakova NN, Pershina OV, Pakhomova AV, Putrova OD, Sandrikina LA, Krupin VA, Kogai LV, Rebrova TY, Afanas'ev SA, Dygai AM. Age-Related Features of the Response of the Liver and Stem Cells during Modeling of Liver Cirrhosis. Bull Exp Biol Med 2021;171:127-33. [PMID: 34046793 DOI: 10.1007/s10517-021-05184-6] [Reference Citation Analysis]
|
| 112 |
Wang Y, Zhang H, Wang H. Progress of Interference of Traditional Chinese Medicine on Cirrhosis Treated with Bone Marrow Mesenchymal Stem Cells. Evid Based Complement Alternat Med 2021;2021:5569274. [PMID: 34055009 DOI: 10.1155/2021/5569274] [Reference Citation Analysis]
|
| 113 |
Golonka RM, Cooper JK, Issa R, Devarasetty PP, Gokula V, Busken J, Zubcevic J, Hill J, Vijay-Kumar M, Menon B, Joe B. Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis. Curr Hypertens Rep 2021;23:28. [PMID: 33961141 DOI: 10.1007/s11906-021-01142-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Aurora C, Dorel C, Cecilia A, Adina H. Biochemical and Cytological Changes in Patients with Hepatic Cirrhosis. ARS Medica Tomitana 2021;27:106-109. [DOI: 10.2478/arsm-2021-0019] [Reference Citation Analysis]
|
| 115 |
Bezborodkina NN, Okovityi SV, Kudryavtsev BN. Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver. Cells 2021;10:976. [PMID: 33919385 DOI: 10.3390/cells10050976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 116 |
Dourakis SP, Geladari E, Geladari C, Vallianou N. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased? Curr Cardiol Rev 2021;17:78-84. [PMID: 31072296 DOI: 10.2174/1573403X15666190509084519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 117 |
Sridharan B, Devarajan N, Jobanputra R, Gowd GS, Anna IM, Ashokan A, Nair S, Koyakutty M. nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular Carcinoma. ACS Appl Bio Mater 2021;4:3398-409. [PMID: 35014424 DOI: 10.1021/acsabm.1c00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Pomacu MM, Trașcă MD, Pădureanu V, Bugă AM, Andrei AM, Stănciulescu EC, Baniță IM, Rădulescu D, Pisoschi CG. Interrelation of inflammation and oxidative stress in liver cirrhosis. Exp Ther Med 2021;21:602. [PMID: 33936259 DOI: 10.3892/etm.2021.10034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 119 |
Chen L, Guo P, Li W, Fang F, Zhu W, Fan J, Wang F, Gao Y, Zhao Q, Wang Q, Xiao Y, Xing X, Li D, Shi T, Yu D, Aschner M, Zhang L, Chen W. Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis. Hepatology 2021;73:1551-69. [PMID: 32654205 DOI: 10.1002/hep.31457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 120 |
Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNA Interference in Hepatic Host-Pathogen Interactions. Int J Mol Sci 2021;22:3554. [PMID: 33808062 DOI: 10.3390/ijms22073554] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 121 |
Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 122 |
Rahman MM, Shahab NB, Miah P, Rahaman MM, Kabir AU, Subhan N, Khan AA, Afroze M, Khan M, Ahmed KS, Hossain H, Haque MA, Alam MA. Polyphenol-rich leaf of Aphanamixis polystachya averts liver inflammation, fibrogenesis and oxidative stress in ovariectomized Long-Evans rats. Biomed Pharmacother 2021;138:111530. [PMID: 33773464 DOI: 10.1016/j.biopha.2021.111530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 123 |
Cadney MD, Hiramatsu L, Thompson Z, Zhao M, Kay JC, Singleton JM, Albuquerque RL, Schmill MP, Saltzman W, Garland T Jr. Effects of early-life exposure to Western diet and voluntary exercise on adult activity levels, exercise physiology, and associated traits in selectively bred High Runner mice. Physiol Behav 2021;234:113389. [PMID: 33741375 DOI: 10.1016/j.physbeh.2021.113389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 124 |
Awan T, Babendreyer A, Wozniak J, Alvi AM, Sterzer V, Cook L, Bartsch JW, Liedtke C, Yildiz D, Ludwig A. Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release In Vitro. Mediators Inflamm 2021;2021:6665028. [PMID: 33814981 DOI: 10.1155/2021/6665028] [Reference Citation Analysis]
|
| 125 |
Itoudi Bignoumba PE, Alilangori T, Mackossot A, Maganga Moussavou IF, Eyi Nguema AG, Mbounja M, Nzouto P, Saibou M, Moussavou Kombila JB. The cost of clinical treatment for decompensated cirrhosis at the university hospital center of Libreville. GHOA 2021;11:65-67. [DOI: 10.15406/ghoa.2020.11.00415] [Reference Citation Analysis]
|
| 126 |
Li W, Li P, Li N, Du Y, Lü S, Elad D, Long M. Matrix stiffness and shear stresses modulate hepatocyte functions in a fibrotic liver sinusoidal model. Am J Physiol Gastrointest Liver Physiol 2021;320:G272-82. [PMID: 33296275 DOI: 10.1152/ajpgi.00379.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 127 |
Zhou J, Wang W, Li Q. Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages. J Exp Clin Cancer Res 2021;40:73. [PMID: 33596985 DOI: 10.1186/s13046-021-01873-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 128 |
Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J Clin Med 2021;10:702. [PMID: 33670126 DOI: 10.3390/jcm10040702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 129 |
Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 130 |
Tang S, Huang Z, Jiang J, Gao J, Zhao C, Tai Y, Ma X, Zhang L, Ye Y, Gan C, Su W, Jia X, Liu R, Wu H, Tang C. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats. Life Sci 2021;272:119203. [PMID: 33577848 DOI: 10.1016/j.lfs.2021.119203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 131 |
Ala M, Mohammad Jafari R, Hajiabbasi A, Dehpour AR. Aquaporins and diseases pathogenesis: From trivial to undeniable involvements, a disease-based point of view. J Cell Physiol 2021;236:6115-35. [PMID: 33559160 DOI: 10.1002/jcp.30318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 132 |
Chen D, Wen S, Wu Z, Gu Y, Chen Y, Chen X, Zhang Y, Lin B, Peng L, Zheng Y, Gao Z. Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure. Eur J Gastroenterol Hepatol 2021;32:246-54. [PMID: 32282547 DOI: 10.1097/MEG.0000000000001721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 133 |
Yang Y, Min Z. Effect of long non‑coding RNA AK021443 on promoting hepatic fibrosis in vitro. Mol Med Rep 2021;23:196. [PMID: 33495828 DOI: 10.3892/mmr.2021.11835] [Reference Citation Analysis]
|
| 134 |
Fang H, Yu L, You D, Peng N, Guo W, Wang J, Zhang X. In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis. Front Bioeng Biotechnol 2020;8:613784. [PMID: 33553120 DOI: 10.3389/fbioe.2020.613784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 135 |
Cam I, Gencturk M, Lim N, Sharma S, Wong J, Yang M, Golzarian J, Flanagan S, Young S. Alcohol Recidivism Following Transjugular Intrahepatic Portosystemic Shunt Placement: Frequency and Predictive Factors. Cardiovasc Intervent Radiol 2021;44:758-65. [PMID: 33415418 DOI: 10.1007/s00270-020-02754-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 136 |
Mokhtari F, Mohebbi SR, Sharifian A, Ramandi M, Razzaghi MR. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases. Gastroenterol Hepatol Bed Bench 2021;14:S10-23. [PMID: 35154598] [Reference Citation Analysis]
|
| 137 |
Warner S, Kelly DA. Liver Failure. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00077-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 138 |
Petrushenko VV, Grebeniuk DI, Lonskii KL, Gladkykh VY, Kedyk OO, Rosha LH. EFFICACY OF L-ORNITHINE L-ASPARTATE IN PATIENTS WITH ESOPHAGEAL VARICEAL BLEEDING. WOMAB 2021;17:112. [DOI: 10.26724/2079-8334-2021-2-76-112-117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 139 |
Katsin M, Hurava M, Prylutski P, Dzyadz'ko A, Rummo O. Pathogenesis and clinical significance of the hyperdynamic circulatory syndrome in liver cirrhosis. Review. Annals of critical care 2021. [DOI: 10.21320/1818-474x-2021-1-123-133] [Reference Citation Analysis]
|
| 140 |
Guragac Dereli FT, Guragac A, Belwal T. Introduction. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 2021. [DOI: 10.1016/b978-0-12-816488-4.00011-5] [Reference Citation Analysis]
|
| 141 |
Baron MV, Scherer GDLG, dos Santos MP, Santamaria AFM, Brandenburg C, Reinheimer IC, de Mello Pinto MV, Sampaio AR, Sancho AG, Sancho AG, Pacheco EF, Picariello F, de Mello Florentino D, Ott JN, Pinheiro CG, Iketani NKP, Carvalho S, Meyer PF, da Costa BEP. Early Hepatic Encephalopathy after a Transjugular Intrahepatic Portosystemic Shunt Procedure: Case Report. OJGas 2021;11:81-88. [DOI: 10.4236/ojgas.2021.116009] [Reference Citation Analysis]
|
| 142 |
Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 24.5] [Reference Citation Analysis]
|
| 143 |
Yang G, Zhan J, Yang Y, Yuan L, Wang P, Ho C, Li S. Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis. Food Science and Human Wellness 2021;10:6-12. [DOI: 10.1016/j.fshw.2020.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 144 |
Obulesu M. Curcumin in liver disease treatment. Turmeric and Curcumin for Neurodegenerative Diseases 2021. [DOI: 10.1016/b978-0-12-822448-9.00004-2] [Reference Citation Analysis]
|
| 145 |
Kweon M, Kim JY, Jun JH, Kim GJ. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. Int J Mol Sci 2020;22:E239. [PMID: 33383629 DOI: 10.3390/ijms22010239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 146 |
Bai R, Bai M, Zhao Z, Chen N, Yang Y, Tang Z. Alternation of supragingival microbiome in patients with cirrhosis of different Child-Pugh scores. Oral Dis 2020. [PMID: 33274586 DOI: 10.1111/odi.13743] [Reference Citation Analysis]
|
| 147 |
Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 148 |
Smith-Cortinez N, van Eunen K, Heegsma J, Serna-Salas SA, Sydor S, Bechmann LP, Moshage H, Bakker BM, Faber KN. Simultaneous Induction of Glycolysis and Oxidative Phosphorylation during Activation of Hepatic Stellate Cells Reveals Novel Mitochondrial Targets to Treat Liver Fibrosis. Cells 2020;9:E2456. [PMID: 33187083 DOI: 10.3390/cells9112456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 149 |
Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 150 |
Fu LY, Wang SW, Hu MY, Jiang ZL, Shen LL, Zhou YP, Guo JM, Hu YR. Circular RNAs in liver diseases: Mechanisms and therapeutic targets. Life Sci 2021;264:118707. [PMID: 33144187 DOI: 10.1016/j.lfs.2020.118707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 151 |
Olsavszky V, Sticht C, Schmid CD, Winkler M, Wohlfeil SA, Olsavszky A, Schledzewski K, Géraud C, Goerdt S, Leibing T, Koch PS. Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells. Gene 2021;768:145284. [PMID: 33130055 DOI: 10.1016/j.gene.2020.145284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 152 |
Munday JS, Ridler A, Aberdein D, Thomson NA, Griffiths K. Chronic facial eczema in sheep: description of gross and histological changes in the liver and association with serum gamma-glutamyltransferase activity at the time of sporidesmin intoxication. N Z Vet J 2021;69:104-12. [PMID: 32981484 DOI: 10.1080/00480169.2020.1823904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 153 |
D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 76] [Article Influence: 25.7] [Reference Citation Analysis]
|
| 154 |
Schwope RB, Katz M, Russell T, Reiter MJ, Lisanti CJ. The many faces of cirrhosis. Abdom Radiol (NY) 2020;45:3065-80. [PMID: 31190090 DOI: 10.1007/s00261-019-02095-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 155 |
Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:377. [PMID: 32883343 DOI: 10.1186/s13287-020-01895-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 156 |
Zhang C, Han D. The value of color Doppler ultrasound in the diagnosis of upper gastrointestinal hemorrhage in patients with liver cirrhosis. Panminerva Med 2021;63:570-1. [PMID: 32875781 DOI: 10.23736/S0031-0808.20.04071-9] [Reference Citation Analysis]
|
| 157 |
Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 2020;131:110680. [PMID: 32861071 DOI: 10.1016/j.biopha.2020.110680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 158 |
Sawalha K, Kadado AJ, Gupta K, Al-Akchar M, Battisha A, Abozenah M, Salerno C, Gupta M, Khan A, Islam AM. Outcomes of MitraClip Placement in Patients With Liver Cirrhosis. Cardiovasc Revasc Med 2021;29:50-3. [PMID: 32839129 DOI: 10.1016/j.carrev.2020.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 159 |
Riaz F, Li D. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Curr Gene Ther 2019;19:305-17. [PMID: 31696817 DOI: 10.2174/1566523219666191107113046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 160 |
Lin L, Chen G, Chen Z, Lu J, Zhu W, Zhong J, Peng F, Huang A. Prognostic value of tumor stromal collagen features in patients with hepatocellular carcinoma revealed by second-harmonic generation microscopy. Exp Mol Pathol 2020;116:104513. [PMID: 32735795 DOI: 10.1016/j.yexmp.2020.104513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 161 |
de Castro GLC, Bichara CDA, Santiago AM, de Brito WB, Pereira LMS, Moura TCF, da Silva Graça Amoras E, de Araújo MSM, da Silva Conde SRS, Queiroz MAF, Ishak R, Vallinoto ACR. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis C. Heliyon 2020;6:e04524. [PMID: 32743104 DOI: 10.1016/j.heliyon.2020.e04524] [Reference Citation Analysis]
|
| 162 |
Wang T, Lin D, Zhang Y, Zhang Y, Li N. Plasma microRNAs as predictive biomarkers of liver fibrosis and cirrhosis in patients with HBV-associated disease.. [DOI: 10.1101/2020.07.21.213546] [Reference Citation Analysis]
|
| 163 |
George J, Tsuchishima M, Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (Berl) 2020;98:1203-13. [PMID: 32666246 DOI: 10.1007/s00109-020-01950-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 164 |
Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Vitamin D-related immunomodulation in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:867-76. [PMID: 31789949 DOI: 10.1097/MEG.0000000000001597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 165 |
Chen Y, Fan Y, Guo DY, Xu B, Shi XY, Li JT, Duan LF. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother 2020;129:110413. [PMID: 32570119 DOI: 10.1016/j.biopha.2020.110413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 166 |
Yao Y, Yang D, Huang Y, Dong M. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis. Clin Chim Acta 2020;505:141-7. [PMID: 32119835 DOI: 10.1016/j.cca.2020.02.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 167 |
Xu T, Pan L, Li L, Hu S, Zhou H, Yang C, Yang J, Li H, Liu Y, Meng X, Li J. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88. J Cell Mol Med 2020;24:7127-40. [PMID: 32463570 DOI: 10.1111/jcmm.15119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 168 |
Qiu R, Murata S, Oshiro K, Hatada Y, Taniguchi H. Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model. Sci Rep 2020;10:8231. [PMID: 32427847 DOI: 10.1038/s41598-020-65069-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 169 |
Tietze L, Kessler SM. The Good, the Bad, the Question-H19 in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1261. [PMID: 32429417 DOI: 10.3390/cancers12051261] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 170 |
Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 198] [Cited by in F6Publishing: 218] [Article Influence: 66.0] [Reference Citation Analysis]
|
| 171 |
Mohanty SK, Lobeck I, Donnelly B, Dupree P, Walther A, Mowery S, Coots A, Bondoc A, Sheridan RM, Poling HM, Temple H, McNeal M, Sestak K, Bansal R, Tiao G. Rotavirus Reassortant-Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia. Hepatology 2020;71:1316-30. [PMID: 31442322 DOI: 10.1002/hep.30907] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 172 |
Luo L, Zhang G, Mao L, Wang P, Xi C, Shi G, Leavenworth JW. Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway. Toxicol Appl Pharmacol 2020;395:114978. [PMID: 32234387 DOI: 10.1016/j.taap.2020.114978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 173 |
Strathearn LS, Stepanov AI, Font-Burgada J. Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020;12:E933. [PMID: 32230953 DOI: 10.3390/nu12040933] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 174 |
Ghobadi Pour M, Mirazi N, Alaei H, Radahmadi M, Rajaei Z, Monsef Esfahani A. The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats. Bioimpacts 2020;10:177-86. [PMID: 32793440 DOI: 10.34172/bi.2020.22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 175 |
Ye L, Yu Y, Zhao Y. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol 2020;35:482-91. [PMID: 31617598 DOI: 10.1111/jgh.14875] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 176 |
Zaffaroni G, Okawa S, Morales-Ruiz M, Del Sol A. An integrative method to predict signalling perturbations for cellular transitions. Nucleic Acids Res 2019;47:e72. [PMID: 30949696 DOI: 10.1093/nar/gkz232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 177 |
Ignat SR, Dinescu S, Hermenean A, Costache M. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development. Cells 2020;9:E461. [PMID: 32085494 DOI: 10.3390/cells9020461] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 178 |
Fu J, Wu B, Wu H, Lin F, Deng W. Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis. BMC Med Imaging 2020;20:16. [PMID: 32046659 DOI: 10.1186/s12880-020-0414-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 179 |
Zadorozhna M, Di Gioia S, Conese M, Mangieri D. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Mol Biol Rep 2020;47:2279-88. [PMID: 32040707 DOI: 10.1007/s11033-020-05290-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 180 |
Chen VL, Chen Y, Du X, Handelman SK, Speliotes EK. Genetic variants that associate with cirrhosis have pleiotropic effects on human traits. Liver Int 2020;40:405-15. [PMID: 31815349 DOI: 10.1111/liv.14321] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 181 |
Khan M, Vaidyanath A, Suresh D, Vaishnav B, Kakrani AL, Patil S, Shiras A. Generation and characterization of three clones (NCCSi007A, NCCSi007B and NCCSi007C) of an integration free induced Pluripotent Stem Cell line from a patient with alcoholic liver cirrhosis of Indian ethnicity. Stem Cell Research 2020;42:101678. [DOI: 10.1016/j.scr.2019.101678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 182 |
Abrahamovych MO, Abrahamovych OO, Fayura OP, Fayura LR. REDOX-HOMEOSTASIS FEATURES IN PATIENTS WITH LIVER CIRRHOSIS DEPENDING ON SEVERITY OF THE INTERNAL ORGANS SYNTROPIC COMORBID LESIONS. EUMJ 2020;8:24-38. [DOI: 10.21272/eumj.2020;8(1):24-33] [Reference Citation Analysis]
|
| 183 |
Land WG. Solid Organ Injury. Damage-Associated Molecular Patterns in Human Diseases 2020. [DOI: 10.1007/978-3-030-53868-2_9] [Reference Citation Analysis]
|
| 184 |
Abrahamovych M, The Danylo Halytsky National Medical University in Lviv, Abrahamovych O, Fayura O, Fayura L, The Danylo Halytsky National Medical University in Lviv, The Danylo Halytsky National Medical University in Lviv, Institute of Cell Biology, National Academy of Sciences of Ukraine. Features of redox homeostasis in patients with liver cirrhosis (literature review and clinical case description). AML 2020;26:70-86. [DOI: 10.25040/aml2020.01.070] [Reference Citation Analysis]
|
| 185 |
Abrahamovych M, Danylo Halytsky Lviv National Medical University, Abrahamovych O, Fayura O, Tolopko S, Ferko M, Danylo Halytsky Lviv National Medical University, Danylo Halytsky Lviv National Medical University, Danylo Halytsky Lviv National Medical University, Danylo Halytsky Lviv National Medical University. Content of Some Endothotelium-Dependent Vasoactive Substances in the Blood of Patients, Depending on the Liver Cirrhosis Severity and the Organism’s Redox System State. Lʹviv klin visn 2019;4:14-20. [DOI: 10.25040/lkv2019.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 186 |
Akbari S, Arslan N, Senturk S, Erdal E. Next-Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol 2019;7:345. [PMID: 31921856 DOI: 10.3389/fcell.2019.00345] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 187 |
Sharma R, Reiter RJ, Ma Q. Melatonin: A hypothesis regarding its use to treat Wilson disease. Medical Hypotheses 2019;133:109408. [DOI: 10.1016/j.mehy.2019.109408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 188 |
Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 189 |
Yoo HJ, Jung KJ, Kim M, Kim M, Kang M, Jee SH, Choi Y, Lee JH. Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls. Front Physiol 2019;10:1421. [PMID: 31803070 DOI: 10.3389/fphys.2019.01421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 190 |
Seo HY, Lee SH, Lee JH, Kang YN, Choi YK, Hwang JS, Park KG, Jang BK, Kim MK. Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway. Cells 2019;8:E1442. [PMID: 31739636 DOI: 10.3390/cells8111442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 191 |
Huang KC, Chuang MH, Lin ZS, Lin YC, Chen CH, Chang CL, Huang PC, Syu WS, Chiou TW, Hong ZH, Tsai YC, Harn HJ, Lin PC, Lin SZ. Transplantation with GXHPC1 for Liver Cirrhosis: Phase 1 Trial. Cell Transplant 2019;28:100S-11S. [PMID: 31722556 DOI: 10.1177/0963689719884885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 192 |
Chen CH, Chang CL, Chen KH, Cheng BC, Chen HH, Chiang JY, Sung PH, Yip HK. Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients. In Vivo 2019;33:2265-72. [PMID: 31662566 DOI: 10.21873/invivo.11732] [Reference Citation Analysis]
|
| 193 |
Philips CA, Augustine P, Ahamed R, Rajesh S, George T, Valiathan GC, John SK. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering'. J Clin Transl Hepatol 2019;7:371-83. [PMID: 31915607 DOI: 10.14218/JCTH.2019.00034] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 194 |
Meng X, Wang H, Song X, Clifton AC, Xiao J. The potential role of senescence in limiting fibrosis caused by aging. J Cell Physiol 2020;235:4046-59. [PMID: 31637710 DOI: 10.1002/jcp.29313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 195 |
Bellan M, Cittone MG, Tonello S, Rigamonti C, Castello LM, Gavelli F, Pirisi M, Sainaghi PP. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. Int J Mol Sci 2019;20:E5070. [PMID: 31614787 DOI: 10.3390/ijms20205070] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 196 |
Furuya K, Zheng YW, Sako D, Iwasaki K, Zheng DX, Ge JY, Liu LP, Furuta T, Akimoto K, Yagi H, Hamada H, Isoda H, Oda T, Ohkohchi N. Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment. World J Stem Cells 2019;11:705-21. [PMID: 31616545 DOI: 10.4252/wjsc.v11.i9.705] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 197 |
Ezzeldin S, El-Wazir A, Enany S, Muhammad A, Johar D, Osama A, Ahmed E, Shikshaky H, Magdeldin S. Current Understanding of Human Metaproteome Association and Modulation. J Proteome Res 2019;18:3539-54. [PMID: 31262181 DOI: 10.1021/acs.jproteome.9b00301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 198 |
Soria-Jasso LE, Cariño-Cortés R, Muñoz-Pérez VM, Pérez-Hernández E, Pérez-Hernández N, Fernández-Martínez E. Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver. Int J Mol Sci 2019;20:E4694. [PMID: 31546715 DOI: 10.3390/ijms20194694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 199 |
Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 200 |
Hu C, Zhao L, Tao J, Li L. Protective role of melatonin in early-stage and end-stage liver cirrhosis. J Cell Mol Med 2019;23:7151-62. [PMID: 31475778 DOI: 10.1111/jcmm.14634] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 201 |
Lee YH, Son JY, Kim KS, Park YJ, Kim HR, Park JH, Kim KB, Lee KY, Kang KW, Kim IS, Kacew S, Lee BM, Kim HS. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats. Int J Mol Sci 2019;20:E3709. [PMID: 31362375 DOI: 10.3390/ijms20153709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 202 |
Cao G, Zhu R, Jiang T, Tang D, Kwan HY, Su T. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling. Phytomedicine 2019;63:153055. [PMID: 31377585 DOI: 10.1016/j.phymed.2019.153055] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 203 |
Lee JW, Ko J, Ju C, Eltzschig HK. Hypoxia signaling in human diseases and therapeutic targets. Exp Mol Med. 2019;51:1-13. [PMID: 31221962 DOI: 10.1038/s12276-019-0235-1] [Cited by in Crossref: 105] [Cited by in F6Publishing: 138] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 204 |
Günther C, Brevini T, Sampaziotis F, Neurath MF. What gastroenterologists and hepatologists should know about organoids in 2019. Dig Liver Dis 2019;51:753-60. [PMID: 30948332 DOI: 10.1016/j.dld.2019.02.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 205 |
Liu H, Zhang S, Xu S, Koroleva M, Small EM, Jin ZG. Myofibroblast-specific YY1 promotes liver fibrosis. Biochem Biophys Res Commun 2019;514:913-8. [PMID: 31084931 DOI: 10.1016/j.bbrc.2019.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 206 |
Chokesuwattanaskul R, Thongprayoon C, Bathini T, O'Corragain OA, Sharma K, Preechawat S, Wijarnpreecha K, Kröner PT, Ungprasert P, Cheungpasitporn W. Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: a meta-analysis. Eur J Gastroenterol Hepatol 2019;31:514-9. [PMID: 30451705 DOI: 10.1097/MEG.0000000000001315] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 207 |
Li Y, Yan Y, Liu F, Wang L, Feng F, Xiao Y. Effects of calpain inhibitor on the apoptosis of hepatic stellate cells induced by calcium ionophore A23187. J Cell Biochem 2019;120:1685-93. [PMID: 30191626 DOI: 10.1002/jcb.27478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 208 |
Moon H, Cho K, Shin S, Kim DY, Han KH, Ro SW. High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway. Int J Mol Sci. 2019;20. [PMID: 30700007 DOI: 10.3390/ijms20030581] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 209 |
Pradhan-Sundd T, Monga SP. Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology. Gene Expr 2019;19:69-87. [PMID: 30646969 DOI: 10.3727/105221619X15469715711907] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 210 |
Wang P, Lei S, Wang X, Xu W, Hu P, Chen F, Zhang X, Yin C, Xie W. MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1. Biochem Cell Biol 2019;97:505-12. [PMID: 30645141 DOI: 10.1139/bcb-2018-0211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 211 |
Yokoyama T, Yagi Mendoza H, Tanaka T, Ii H, Takano R, Yaegaki K, Ishikawa H. Regulation of CCl4-induced liver cirrhosis by hepatically differentiated human dental pulp stem cells. Hum Cell 2019;32:125-40. [PMID: 30637566 DOI: 10.1007/s13577-018-00234-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 212 |
Sisto M, Ribatti D, Lisi S. Aquaporin water channels: New perspectives on the potential role in inflammation. Adv Protein Chem Struct Biol 2019;116:311-45. [PMID: 31036295 DOI: 10.1016/bs.apcsb.2018.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 213 |
Rajapaksha IG, Angus PW, Herath CB. Current therapies and novel approaches for biliary diseases. World J Gastrointest Pathophysiol 2019; 10(1): 1-10 [PMID: 30622832 DOI: 10.4291/wjgp.v10.i1.1] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 214 |
Cooper M, Charest JL, Coppeta J. Design principles for dynamic microphysiological systems. Microfluidic Cell Culture Systems 2019. [DOI: 10.1016/b978-0-12-813671-3.00001-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 215 |
Hickman L, Tanner L, Christein J, Vickers S. Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease. J Gastrointest Surg 2019;23:634-42. [PMID: 30465191 DOI: 10.1007/s11605-018-3991-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 216 |
Pérez-monter C, Escalona-nandez I, Estanes-hernández A, Noriega-lópez L, Torre-delgadillo A. Determinación de la microbiota intestinal en pacientes cirróticos de población mestizo-mexicana. Revista de Gastroenterología de México 2019;84:26-35. [DOI: 10.1016/j.rgmx.2018.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 217 |
Liu T, Xu L, Wang C, Chen K, Xia Y, Li J, Li S, Wu L, Feng J, Xu S, Wang W, Lu X, Fan X, Mo W, Zhou Y, Zhao Y, Guo C. Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor-β1/Smads pathway through shikonin. J Gastroenterol Hepatol 2019;34:263-76. [PMID: 29864192 DOI: 10.1111/jgh.14299] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 218 |
Pérez-monter C, Escalona-nandez I, Estanes-hernández A, Noriega-lópez L, Torre-delgadillo A. Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population. Revista de Gastroenterología de México (English Edition) 2019;84:26-35. [DOI: 10.1016/j.rgmxen.2018.08.005] [Reference Citation Analysis]
|
| 219 |
Kemp L, Clare KE, Brennan PN, Dillon JF. New horizons in hepatitis B and C in the older adult. Age Ageing 2019;48:32-7. [PMID: 30379991 DOI: 10.1093/ageing/afy170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 220 |
Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17:1919-1929. [PMID: 30783469 DOI: 10.3892/etm.2018.7117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 221 |
Mohammed H, Varoni EM, Cochis A, Cordaro M, Gallenzi P, Patini R, Staderini E, Lajolo C, Rimondini L, Rocchetti V. Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature. Biomedicines 2018;6:E115. [PMID: 30544974 DOI: 10.3390/biomedicines6040115] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 222 |
Zhang Y, Li R, Rong W, Han M, Cui C, Feng Z, Sun X, Jin S. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.Cell Death Dis. 2018;9:1186. [PMID: 30538216 DOI: 10.1038/s41419-018-1239-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 223 |
Orbach SM, Ford AJ, Saverot SE, Rajagopalan P. Multi-cellular transitional organotypic models to investigate liver fibrosis. Acta Biomater 2018;82:79-92. [PMID: 30316024 DOI: 10.1016/j.actbio.2018.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 224 |
Liu L, Zhou Y, Dai D, Xia H, Zhao K, Zhang J. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet. Biomedicine & Pharmacotherapy 2018;108:424-34. [DOI: 10.1016/j.biopha.2018.06.134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 225 |
Emara DM, Reda MM, Elwazzan DA. Utility of diffusion weighted imaging (DWI) in assessment of liver fibrosis. Alexandria Journal of Medicine 2018;54:347-352. [DOI: 10.1016/j.ajme.2017.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 226 |
Sung S, Kim J, Jung Y. Liver-Derived Exosomes and Their Implications in Liver Pathobiology. Int J Mol Sci 2018;19:E3715. [PMID: 30469540 DOI: 10.3390/ijms19123715] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 227 |
Zhang Y, Ma LT, Li J, Qiao Y, Liu JY, Wang J, Ren QY, Hu JT, Zheng J. Anti-fibrotic Effects and Mechanism of Shengmai Injection () on Human Hepatic Stellate Cells LX-2. Chin J Integr Med 2019;25:197-202. [PMID: 30467694 DOI: 10.1007/s11655-018-2849-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 228 |
Fathy M, Khalifa EMMA, Fawzy MA. Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats. Life Sci 2019;216:207-14. [PMID: 30452970 DOI: 10.1016/j.lfs.2018.11.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 229 |
Tan L, Meng Y, Zeng T, Wang Q, Long T, Wu S, Guan X, Fu H, Zheng W, Tian Y, Chen J, Yu J, Wu Y, Li H, Cao L. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy. Br J Biomed Sci 2019;76:24-8. [PMID: 30392460 DOI: 10.1080/09674845.2018.1523673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 230 |
Maslennikov R, Pavlov C, Ivashkin V. Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis. Hepatol Int 2018;12:567-76. [PMID: 30284684 DOI: 10.1007/s12072-018-9898-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 231 |
O’Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer. World J Gastroenterol 2018; 24(39): 4436-4447 [PMID: 30357021 DOI: 10.3748/wjg.v24.i39.4436] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 84] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 232 |
Kaliszewski E, Parker A. Severe Protein Calorie Malnutrition in the Context of Alcoholic Liver Cirrhosis: A Case Study Evaluation. Topics in Clinical Nutrition 2018;33:335-45. [DOI: 10.1097/tin.0000000000000157] [Reference Citation Analysis]
|
| 233 |
Sun J, Li Y, Sun X, Yu H, Liu Y. Dynamic Changes of the Aspartate Aminotransferase-to-Platelet Ratio and Transient Elastography in Predicting a Histologic Response in Patients With Chronic Hepatitis B After Entecavir Treatment. J Ultrasound Med 2019;38:1441-8. [PMID: 30244494 DOI: 10.1002/jum.14822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 234 |
Triantos C, Aggeletopoulou I, Kalafateli M, Spantidea PI, Vourli G, Diamantopoulou G, Tapratzi D, Michalaki M, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis. Sci Rep 2018;8:14065. [PMID: 30218108 DOI: 10.1038/s41598-018-32482-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 235 |
Ali FE, Bakr AG, Abo-youssef AM, Azouz AA, Hemeida RA. Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis. Life Sciences 2018;207:50-60. [DOI: 10.1016/j.lfs.2018.05.048] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 236 |
Liu J, Yang P, Zuo G, He S, Tan W, Zhang X, Su C, Zhao L, Wei L, Chen Y, Ruan X, Chen Y. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Lipids Health Dis 2018;17:153. [PMID: 30016988 DOI: 10.1186/s12944-018-0790-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 237 |
Nallagangula KS, Lakshmaiah V, Muninarayana C, Deepa KV, Shashidhar KN. A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis. J Circ Biomark 2018;7:1849454418788417. [PMID: 30034555 DOI: 10.1177/1849454418788417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 238 |
Ohara M, Ohnishi S, Hosono H, Yamamoto K, Fu Q, Maehara O, Suda G, Sakamoto N. Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. Front Pharmacol 2018;9:709. [PMID: 30057547 DOI: 10.3389/fphar.2018.00709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 239 |
Bellan M, Castello LM, Pirisi M. Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review. J Clin Transl Hepatol 2018;6:317-25. [PMID: 30271745 DOI: 10.14218/JCTH.2018.00006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 240 |
Li RK, Ren XP, Yan FH, Qiang JW, Lin HM, Tao Wang, Zhao HF, Chen WB. Liver fibrosis detection and staging: a comparative study of T1ρ MR imaging and 2D real-time shear-wave elastography. Abdom Radiol (NY) 2018;43:1713-22. [PMID: 29198003 DOI: 10.1007/s00261-017-1381-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 241 |
Wang J, Zhang Q, Cheng J, Chen L, Yao N, Sun G, Chu Y. Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road. Chin J Integr Med 2018;24:713-20. [DOI: 10.1007/s11655-018-3007-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 242 |
Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2018;10:133-148. [PMID: 30186577 DOI: 10.15171/mejdd.2018.103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 243 |
Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines (Basel). 2018;5. [PMID: 29890719 DOI: 10.3390/medicines5020052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 244 |
Du P, Ma Q, Xiong J, Wang Y, Yang F, Jin F, Chen Y, Shang Z, Chen Z, Zhou X, Li H, Zhao L. Corilagin controls post-parasiticide schistosome egg-induced liver fibrosis by inhibiting Stat6 signalling pathway.. [DOI: 10.1101/340299] [Reference Citation Analysis]
|
| 245 |
Rahimi N, Hassanipour M, Allahabadi NS, Sabbaghziarani F, Yazdanparast M, Dehpour A. Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems. Pharmacological Reports 2018;70:426-33. [DOI: 10.1016/j.pharep.2017.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 246 |
Xu M, Chen L, Li J, Wu H, Xia Q, Kong X. Emerging roles of DJ-1 in liver diseases through regulation of oxidative stress and immune response. Liver Research 2018;2:87-91. [DOI: 10.1016/j.livres.2018.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 247 |
Erstad DJ, Farrar CT, Ghoshal S, Masia R, Ferreira DS, Chen YI, Choi JK, Wei L, Waghorn PA, Rotile NJ, Tu C, Graham-O'Regan KA, Sojoodi M, Li S, Li Y, Wang G, Corey KE, Or YS, Jiang L, Tanabe KK, Caravan P, Fuchs BC. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist. Hepatol Commun 2018;2:821-35. [PMID: 30027140 DOI: 10.1002/hep4.1193] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 248 |
Wang Y, Hong R, Xie Y, Xu J. Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway. CURR MED SCI 2018;38:236-44. [DOI: 10.1007/s11596-018-1871-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 249 |
Ke B, Lee C. Cordyceps cicadae NTTU 868 mycelium prevents CCl 4 -induced hepatic fibrosis in BALB/c mice via inhibiting the expression of pro-inflammatory and pro-fibrotic cytokines. Journal of Functional Foods 2018;43:214-23. [DOI: 10.1016/j.jff.2018.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 250 |
Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructural characteristics of the respective forms of hepatic stellate cells in chronic hepatitis B as an example of high fibroblastic cell plasticity. The first assessment in children. Adv Med Sci 2018;63:127-33. [PMID: 29120853 DOI: 10.1016/j.advms.2017.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 251 |
Buonomo AR, Scotto R, Nappa S, Arcopinto M, Salzano A, Marra AM, D'Assante R, Zappulo E, Borgia G, Gentile I. The role of curcumin in liver diseases. Arch Med Sci 2019;15:1608-20. [PMID: 31749891 DOI: 10.5114/aoms.2018.73596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 252 |
Wang XZ, Huang XY, Yao JG, Wang C, Xia Q, Long XD. Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1. Oncotarget 2018;9:27321-32. [PMID: 29937988 DOI: 10.18632/oncotarget.24535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 253 |
Saks K, Jensen KK, McLouth J, Hum J, Ahn J, Zaman A, Chang MF, Fung A, Schlansky B. Influence of spontaneous splenorenal shunts on clinical outcomes in decompensated cirrhosis and after liver transplantation. Hepatol Commun 2018;2:437-44. [PMID: 29619421 DOI: 10.1002/hep4.1157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 254 |
Singh A, Pandey B. A New Intelligent Medical Decision Support System Based on Enhanced Hierarchical Clustering and Random Decision Forest for the Classification of Alcoholic Liver Damage, Primary Hepatoma, Liver Cirrhosis, and Cholelithiasis. J Healthc Eng 2018;2018:1469043. [PMID: 29599940 DOI: 10.1155/2018/1469043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 255 |
Sy BT, Hoan NX, Tong HV, Meyer CG, Toan NL, Song LH, Bock CT, Velavan TP. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection. World J Gastroenterol 2018; 24(2): 248-256 [PMID: 29375210 DOI: 10.3748/wjg.v24.i2.248] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 256 |
Li Y, Yan Y, Liu F, Wang M, Feng F, Xiao Y. Effects of calcium Ionophore A23187 on the apoptosis of hepatic stellate cells stimulated by transforming growth factor-β1. Cell Mol Biol Lett 2018;23:1. [PMID: 29308067 DOI: 10.1186/s11658-017-0063-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 257 |
Pérez-cabeza de Vaca R, Domínguez-lópez M, Guerrero-celis N, Rodríguez-aguilera JR, Chagoya de Sánchez V. Inflammation is regulated by the adenosine derivative molecule, IFC-305, during reversion of cirrhosis in a CCl4 rat model. International Immunopharmacology 2018;54:12-23. [DOI: 10.1016/j.intimp.2017.10.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 258 |
Feng J, Chen K, Xia Y, Wu L, Li J, Li S, Wang W, Lu X, Liu T, Guo C. Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. Drug Des Devel Ther 2018;12:1837-53. [PMID: 29970958 DOI: 10.2147/DDDT.S162950] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 259 |
Herrera B, Addante A, Sánchez A. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. Int J Mol Sci 2017;19:E39. [PMID: 29295498 DOI: 10.3390/ijms19010039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 260 |
Jia Z, Gong Y, Pi Y, Liu X, Gao L, Kang L, Wang J, Yang F, Tang J, Lu W, Li Q, Zhang W, Yan Z, Yu L. pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis. Mol Pharm 2018;15:53-62. [PMID: 29148802 DOI: 10.1021/acs.molpharmaceut.7b00709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 261 |
Ridha A, Al-Abboodi Y, Fasullo M. The Outcome of Thoracentesis versus Chest Tube Placement for Hepatic Hydrothorax in Patients with Cirrhosis: A Nationwide Analysis of the National Inpatient Sample. Gastroenterol Res Pract 2017;2017:5872068. [PMID: 29317865 DOI: 10.1155/2017/5872068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 262 |
Pinheiro D, Leirós L, Dáu JBT, Stumbo AC, Thole AA, Cortez EAC, Mandarim-de-Lacerda CA, Carvalho L, Carvalho SN. Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice. PLoS One 2017;12:e0187970. [PMID: 29176797 DOI: 10.1371/journal.pone.0187970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 263 |
Ni Y, Li JM, Liu MK, Zhang TT, Wang DP, Zhou WH, Hu LZ, Lv WL. Pathological process of liver sinusoidal endothelial cells in liver diseases. World J Gastroenterol 2017; 23(43): 7666-7677 [PMID: 29209108 DOI: 10.3748/wjg.v23.i43.7666] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 264 |
Li J, Zhang X, Chen L, Zhang Z, Zhang J, Wang W, Wu M, Shi B, Zhang X, Kozlowski M, Hu Y, Yuan Z. Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients. Sci Rep. 2017;7:15658. [PMID: 29142236 DOI: 10.1038/s41598-017-15594-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 265 |
Zhang Z, Yao Z, Chen Y, Qian L, Jiang S, Zhou J, Shao J, Chen A, Zhang F, Zheng S. Lipophagy and liver disease: New perspectives to better understanding and therapy. Biomed Pharmacother. 2018;97:339-348. [PMID: 29091883 DOI: 10.1016/j.biopha.2017.07.168] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 266 |
Nallagangula KS, Shashidhar KN, Lakshmaiah V, Muninarayana C. Cirrhosis of liver: Interference of serpins in quantification of SERPINA4 - A preliminary study. Pract Lab Med 2017;9:53-7. [PMID: 29159256 DOI: 10.1016/j.plabm.2017.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 267 |
Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2017;2:e94416. [PMID: 28978799 DOI: 10.1172/jci.insight.94416] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 268 |
Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA 2018;4:FSO250. [PMID: 29255622 DOI: 10.4155/fsoa-2017-0083] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 269 |
Romualdo GR, Grassi TF, Goto RL, Tablas MB, Bidinotto LT, Fernandes AAH, Cogliati B, Barbisan LF. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features. Toxicol Lett 2017;281:84-94. [PMID: 28943392 DOI: 10.1016/j.toxlet.2017.09.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 270 |
Poilil Surendran S, George Thomas R, Moon MJ, Jeong YY. Nanoparticles for the treatment of liver fibrosis. Int J Nanomedicine. 2017;12:6997-7006. [PMID: 29033567 DOI: 10.2147/ijn.s145951] [Cited by in Crossref: 65] [Cited by in F6Publishing: 73] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 271 |
Chang H, Meng HY, Liu SM, Wang Y, Yang XX, Lu F, Wang HY. Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach. Sci Rep 2017;7:11433. [PMID: 28900168 DOI: 10.1038/s41598-017-11759-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 272 |
Ladegaard Grønkjær L, Hoppe Sehstedt T, Norlyk A, Vilstrup H. Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study. Gastroenterol Nurs 2018;41:468-76. [PMID: 28759517 DOI: 10.1097/SGA.0000000000000286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 273 |
de Souza VCA, Pereira TA, Teixeira VW, Carvalho H, de Castro MCAB, D’assunção CG, de Barros AF, Carvalho CL, de Lorena VMB, Costa VMA, Teixeira ÁAC, Figueiredo RCBQ, de Oliveira SA. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. World J Gastroenterol 2017; 23(28): 5146-5157 [PMID: 28811709 DOI: 10.3748/wjg.v23.i28.5146] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 274 |
de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 2017;41:946-59. [PMID: 28498509 DOI: 10.1002/cbin.10790] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 275 |
Ou X, Mao S, Cao J, Ma Y, Ma G, Cheng A, Wang M, Zhu D, Chen S, Jia R, Liu M, Sun K, Yang Q, Wu Y, Chen X. The neglected avian hepatotropic virus induces acute and chronic hepatitis in ducks: an alternative model for hepatology. Oncotarget 2017;8:81838-51. [PMID: 29137226 DOI: 10.18632/oncotarget.19003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 276 |
Karakoyun B. The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68641] [Reference Citation Analysis]
|
| 277 |
Zheng L, Qin J, Sun L, Gui L, Zhang C, Huang Y, Deng W, Huang A, Sun D, Luo M. Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension. Clin Res Hepatol Gastroenterol 2017;41:303-10. [PMID: 28043789 DOI: 10.1016/j.clinre.2016.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 278 |
Fitzpatrick S, Domingo HDA, Finke SM. The Care of the Decompensated Cirrhotic Patient. The Journal for Nurse Practitioners 2017;13:256-263. [DOI: 10.1016/j.nurpra.2016.11.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 279 |
Djiambou-Nganjeu H. Hepatic Encephalopathy in Liver Cirrhosis. J Transl Int Med. 2017;5:64-67. [PMID: 28680841 DOI: 10.1515/jtim-2017-0013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 280 |
Ghobadi Pour M, Mirazi N, Alaei H, Moradkhani S, Rajaei Z, Monsef Esfahani A. Effects of lactulose and silymarin on liver enzymes in cirrhotic rats. Can J Physiol Pharmacol 2017;95:522-9. [PMID: 28281782 DOI: 10.1139/cjpp-2016-0454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 281 |
Gaiping W, Congcong Z, Meng C, Shasha C, Cuifang C, Cunshuan X. Relationship analysis between gene expression profiles and rat liver cirrhosis occurrence. Afr J Biotechnol 2017;16:147-162. [DOI: 10.5897/ajb2016.15718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 282 |
Kershenobich D, Gutiérrez-reyes D. Is Human Cirrhosis a Reversible Disease? Liver Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804274-8.00019-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 283 |
Ismail BES, Rivas JM, Zervos XB. Pathophysiology of Cirrhosis and Portal Hypertension. Surgical Procedures on the Cirrhotic Patient 2017. [DOI: 10.1007/978-3-319-52396-5_1] [Reference Citation Analysis]
|
| 284 |
Abdul-Hamid M, Ahmed RR, Moustafa N, Nady R. The antifibrogenic effect of etanercept on development of liver cirrhosis induced by thioacetamide in rats. Ultrastruct Pathol 2017;41:23-35. [PMID: 27982723 DOI: 10.1080/01913123.2016.1256361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 285 |
Grønkjær LL, Andersen NG, Hansen LB, Sehstedt TH, Svensson NT, Sømod IE, Norlyk A, Bager P. Different views on hepatic encephalopathy: patients, relatives and nurses. Gastrointestinal Nursing 2016;14:S24-31. [DOI: 10.12968/gasn.2016.14.sup10.s24] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 286 |
Mocarzel LO, Bicca J, Jarske L, Oliveira T, Lanzieri P, Gismondi R, Ribeiro ML. Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome. Case Rep Gastroenterol 2016;10:531-7. [PMID: 27843430 DOI: 10.1159/000448885] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 287 |
Guerra S, Mamede AC, Carvalho MJ, Laranjo M, Tralhão JG, Abrantes AM, Maia CJ, Botelho MF. Liver diseases: what is known so far about the therapy with human amniotic membrane? Cell Tissue Bank 2016;17:653-63. [PMID: 27550013 DOI: 10.1007/s10561-016-9579-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 288 |
Iskandarov E, Kadaba Srinivasan P, Xin W, Bleilevens C, Afify M, Hamza A, Wei L, Hata K, Agayev B, Tolba R. Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model. Hepat Mon 2016;16:e36821. [PMID: 27799962 DOI: 10.5812/hepatmon.36821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 289 |
Coscia C, Saxton E, Dickinson S. Postoperative Care of a Liver Transplant Recipient Using a Classification System: Type A (Stable) Versus Type B (Unstable). Crit Care Nurs Q 2016;39:252-66. [PMID: 27254641 DOI: 10.1097/CNQ.0000000000000119] [Reference Citation Analysis]
|
| 290 |
González-Reimers E, Quintero-Platt G, Martín-González C, Pérez-Hernández O, Romero-Acevedo L, Santolaria-Fernández F. Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol 2016; 22(18): 4427-4437 [PMID: 27182154 DOI: 10.3748/wjg.v22.i18.4427] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 291 |
Lam P, Cheung F, Tan HY, Wang N, Yuen MF, Feng Y. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. Int J Mol Sci. 2016;17:465. [PMID: 27043533 DOI: 10.3390/ijms17040465] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 292 |
Shu M, Hu XR, Hung ZA, Huang DD, Zhang S. Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis. Mol Med Rep. 2016;13:3036-3042. [PMID: 26936326 DOI: 10.3892/mmr.2016.4886] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 293 |
Gonzalez RS, Washington K. Fibrosis and Cirrhosis. Non-Neoplastic Liver Pathology 2016. [DOI: 10.1007/978-3-319-31424-2_8] [Reference Citation Analysis]
|
| 294 |
Gudowska M, Gruszewska E, Panasiuk A, Cylwik B, Świderska M, Flisiak R, Szmitkowski M, Chrostek L. Selected Noninvasive Markers in Diagnosing Liver Diseases. Lab Med 2016;47:67-72. [PMID: 26715612 DOI: 10.1093/labmed/lmv015] [Reference Citation Analysis]
|
| 295 |
de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci 2015;16:30269-308. [PMID: 26694382 DOI: 10.3390/ijms161226225] [Cited by in Crossref: 128] [Cited by in F6Publishing: 136] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 296 |
Hedderich DM, Weiss K, Maintz D, Persigehl T. [Modern magnetic resonance imaging of the liver]. Radiologe 2015;55:1045-56. [PMID: 26628259 DOI: 10.1007/s00117-015-0031-4] [Reference Citation Analysis]
|
| 297 |
Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21(41): 11552-11566 [PMID: 26556986 DOI: 10.3748/wjg.v21.i41.11552] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 298 |
Starokozhko V, Abza GB, Maessen HC, Merema MT, Kuper F, Groothuis GM. Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium. Toxicol In Vitro 2015;30:288-99. [PMID: 26514934 DOI: 10.1016/j.tiv.2015.10.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 299 |
Chen S, Chen Y, Chen B, Cai YJ, Zou ZL, Wang JG, Lin Z, Wang XD, Fu LY, Hu YR. Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evid Based Complement Alternat Med. 2015;2015:645727. [PMID: 26550019 DOI: 10.1155/2015/645727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 300 |
Sanchez-Antolín G, Almohalla-Alvarez C, Bueno P, Almansa R, Iglesias V, Rico L, Ortega A, Muñoz-Conejero E, García-Pajares F, Bermejo-Martin JF. Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis. PLoS One 2015;10:e0137128. [PMID: 26317806 DOI: 10.1371/journal.pone.0137128] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 301 |
Muir AJ. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015;37:1822-36. [DOI: 10.1016/j.clinthera.2015.05.507] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 302 |
Lee SL, Chin TY, Lai CL, Wang WH. Sedum mexicanum Britt. Induces Apoptosis of Primary Rat Activated Hepatic Stellate Cells. Evid Based Complement Alternat Med 2015;2015:194373. [PMID: 26078767 DOI: 10.1155/2015/194373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 303 |
Chang WJ, Song LJ, Yi T, Shen KT, Wang HS, Gao XD, Li M, Xu JM, Niu WX, Qin XY. Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury. World J Gastroenterol 2015; 21(14): 4184-4194 [PMID: 25892868 DOI: 10.3748/wjg.v21.i14.4184] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 304 |
Lee PJ, Woo SJ, Jee JG, Sung SH, Kim HP. Bisdemethoxycurcumin Induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2. Molecules. 2015;20:1277-1292. [PMID: 25594342 DOI: 10.3390/molecules20011277] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 305 |
Costas-rodríguez M, Anoshkina Y, Lauwens S, Van Vlierberghe H, Delanghe J, Vanhaecke F. Isotopic analysis of Cu in blood serum by multi-collector ICP-mass spectrometry: a new approach for the diagnosis and prognosis of liver cirrhosis? Metallomics 2015;7:491-8. [DOI: 10.1039/c4mt00319e] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
|
